Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 86667925 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Attorney Name | Anne M. Schneiderman |
Attorney Docket Number | 278093 |
Law Office Assigned | N10 |
Employee Name | RITTNER, HANNO I |
2015-06-19 | Application Filed |
2016-01-19 | Published for Opposition |
2016-10-07 | Location: INTENT TO USE SECTION |
2017-10-16 | Abandon |
2017-10-16 | Status: Dead/Abandoned |
2018-07-08 | Transaction Date |
Owner: | ![]() |
Address | 77 GOODELL STREET SUITE 440 BUFFALO DE 14203 |
Legal Entity Type | Corporation |
Legal Entity State | DE |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 9 |
U.S. Codes: | 021,023,026,036,038 |
International Codes: | 35 |
U.S. Codes: | 100,101,102 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
International Codes: | 44 |
U.S. Codes: | 100,101 |
International Codes: | 45 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0091 | Computer software, for use with medical clinical trial subject monitoring equipment, for receiving, processing, analyzing, transmitting, validating and displaying data; Computer software for controlling and managing patient medical clinical trial information; Computer software for controlling and managing patient medical information for clinical trials; Computer software for controlling and managing point-of-contact electronic data capture of patient visits for clinical trials; Computer software for use by clinical trial subjects for providing clinical trial information, for scheduling appointments and clinical trial visits; Computer software for use by clinical trial subjects for reporting health information, adverse events and side effects of treatment and medication; Computer software for use by clinical trial subjects for clinical trial-related education and information; Computer software for use on a mobile platform for tracking clinical trial subject enrollment, status and adverse/side effects of treatment and medication, metrics on performance by site of clinical trial, and real-time tracking of adverse events |
Description | Date | Event Coding |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2015-06-23 | 1 NWAP I:Incoming Correspondence |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2015-06-24 | 2 NWOS I:Incoming Correspondence |
ASSIGNED TO EXAMINER | 2015-09-28 | 3 DOCK D:Assigned to Examiner |
PRIORITY ACTION WRITTEN | 2015-09-29 | 4 CPRA R:Renewal |
PRIORITY ACTION E-MAILED | 2015-09-29 | 5 GPRA F:First Action |
NOTIFICATION OF PRIORITY ACTION E-MAILED | 2015-09-29 | 6 GPRN O:Outgoing Correspondence |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2015-11-25 | 7 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2015-11-25 | 8 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2015-11-26 | 9 TEME I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2015-11-27 | 10 CNSA P: |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2015-12-30 | 11 NONP E:E-Mail |
PUBLISHED FOR OPPOSITION | 2016-01-19 | 12 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2016-01-19 | 13 NPUB E:E-Mail |
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2016-03-15 | 14 NOAM E:E-Mail |
TEAS EXTENSION RECEIVED | 2016-09-08 | 15 EEXT I:Incoming Correspondence |
EXTENSION 1 FILED | 2016-09-08 | 16 EXT1 S: |
EXTENSION 1 GRANTED | 2016-09-08 | 17 EX1G S: |
TEAS EXTENSION RECEIVED | 2016-09-08 | 18 EEXT I:Incoming Correspondence |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2016-09-10 | 19 EXRA E:E-Mail |
CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2016-09-28 | 20 AITU A:Allowance for Publication |
ITU LETTER MAILED, NO RESPONSE REQUIRED | 2016-09-28 | 21 IULN O:Outgoing Correspondence |
TEAS EXTENSION RECEIVED | 2017-03-10 | 22 EEXT I:Incoming Correspondence |
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2017-03-22 | 23 ASGN I:Incoming Correspondence |
EXTENSION 2 FILED | 2017-03-10 | 24 EXT2 S: |
EXTENSION 2 GRANTED | 2017-03-29 | 25 EX2G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2017-03-30 | 26 EXRA E:E-Mail |
ABANDONMENT - NO USE STATEMENT FILED | 2017-10-16 | 27 ABN6 S: |
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | 2017-10-16 | 28 MAB6 O:Outgoing Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.